Papers

2

Total Citations

6

H-Index

2

About

Dr. Alexis Wang is a urologic oncologist whose research focuses on advancing surgical techniques and understanding rare genitourinary malignancies. Her work is particularly noted for characterizing the learning curve associated with robotic cystectomy with intracorporeal urinary diversion (RCID), a technically demanding procedure for bladder cancer. Using the cumulative sum (CUSUM) method across two institutions, Dr. Wang provided critical insights into the number of cases required for surgical proficiency—a contribution that directly informs training protocols and patient safety. She has also explored diagnostically challenging entities, such as urethral mucinous adenocarcinoma of the prostate, shedding light on uncommon disease presentations that require careful pathological distinction. While her most-cited papers currently hold modest citation counts (2–4), their impact lies in their practical utility for surgeons and pathologists navigating complex clinical scenarios. Dr. Wang’s work bridges the gap between technical innovation and clinical application, offering a roadmap for mastering advanced robotic procedures while expanding the understanding of rare prostate and urethral tumors. Her research is a valuable resource for trainees and specialists seeking to refine surgical outcomes and diagnostic accuracy.

Research Focus

Key Achievements

2
H-Index
2
Papers
6
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Urethral Mucinous Adenocarcinoma of the Prostate: An Uncommon and Diagnostically Complex Disease
4 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Oregon Health & Science University, University of Maryland, Baltimore

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago